Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-17T03:05:48.496Z Has data issue: false hasContentIssue false
  • English
  • Français

PREVENTION OF OBSTETRIC HAEMORRHAGE

Part of: Bespoke shallow archive Weizmann

Published online by Cambridge University Press:  01 August 2007

SOHA SAID  and
MICHAEL GEARY
SOHA SAID
Affiliation:
Rotunda Hospital, Dublin, Republic of Ireland.
MICHAEL GEARY*
Affiliation:
Rotunda Hospital, Dublin, Republic of Ireland.
*
Michael Geary, Rotunda Hospital, Parnell Square, Dublin 1, Republic of Ireland.
Get access Rights & Permissions [Opens in a new window]

Extract

Obstetric haemorrhage has been recognised as a major cause of maternal death as long as physicians have studied and written about childbirth. Until the 20th century, however, little was possible in the way of effective treatment. Postpartum haemorrhage (PPH) is still a frequent cause of death in many parts of the world. Even in developing countries, it remains the 3rd biggest killer of women in childbirth, despite considerable advances in medical care in the last half-century. The modern management of PPH may include a team of anaesthetists, haematologists, vascular surgeons, gynaecologists and radiologists.1 Clearly, this change represents an advance which has saved and will continue to save countless lives, not only in the developed world where such teamwork is routine, but also in developing nations that are desperately looking for ways to reduce maternal mortality as part of their efforts to comply with the United Nations Millennium Development Goals by the year 2015.2

Type
Research Article
Information
Fetal and Maternal Medicine Review , Volume 18 , Issue 3 , August 2007 , pp. 257 - 288
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1Mousa, HA, Walkinshow, S. Major postpartum hemorrhage. Clin Obstet Gynecol 2001; 13: 595–603.Google Scholar
2Gulmezoglu, AM, Villar, J, Ngov, NT. WHO multicentre randomized controlled trial of misoprostol in the management of the third stage of labor. Lancet 2001; 358: 689–95.CrossRefGoogle Scholar
3Prendiville, WJ, Elbourne, D, McDonald, S. Active versus expectant management in the third stage of labor (Cochrane Review). The Cochrane Library. Issue 1. Oxford: Update Software, 2003.Google Scholar
4Chong, YS, Su, LL, Arulkumaran, S. Current srategies for the prevention of postpartum hemorrhage in the third stage of labor. Curr Opin Obstet Gynecol 2004; 16: 143–50.CrossRefGoogle Scholar
5Thomas, J, Koh, S, Cooper, GM. Haemodynamic effects of oxytocin given as IV. bolus or infusion on women undergoing Caesarean section. Br J Anaesthes 2007; 98: 116–19.CrossRefGoogle ScholarPubMed
6T. Liabsuetrakul, TC, Peeyananjarassri, K, Islam, QM. Prophylactic use of ergot alkaloids in the third stage of labor. The Cochrane Library 2007, Issue 2 April 2007.CrossRefGoogle Scholar
7Dansereau, J, Joshi, AK, Helewa, ME. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol 1999; 180: 670–76.CrossRefGoogle ScholarPubMed
8Su, LL, Chong, YS, Chan, ESY, Samuel, M. Oxytocin agoinsts for preventing postpartum hemorrhage (Protocol). Cochrane Database of Systematic Reviews 2005, Issue 3.CrossRefGoogle Scholar
9Sarna, M, Sonia, A, Gomez, M, Oriol, N. Intravenous oxytocin in patients undergoing elective cesarean section. Anesth Analg 1997; 84: 753–56.CrossRefGoogle ScholarPubMed
10Balki, M, Ronayne, M, Davies, S, Fallah, S, Kingdom, J, Windrim, R. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol 2006; 107: 45–50.CrossRefGoogle ScholarPubMed
11Phaneuf, S, Rodriguez Linares, R, Tamby Raja, R, MacKenzie, I. Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmentedlabour. J Reprod Fertil 2000; 120: 91–97.CrossRefGoogle Scholar
12Gulmezoglu, AM, Forna, F, Villar, J, Hofmeyr, GJ. Prostaglandins for prevention of postpartum hemorrhage (Cochrane Review). The Cochrane Liberay. Issue 1. Oxford:Update Software, 2003.CrossRefGoogle Scholar
13Rabe, H, Reynolds, G, Diaz-Rossello, J. Early versus delayed umbilical cord clamping in preterm infants. Cochrane Database of Systematic Reviews 2004, Issue 3.CrossRefGoogle Scholar
14McDonald, SJ, Abbott, JM. Effect of timing of umbilical cord clamping of terms infants on maternal and neonatal outcomes (Protocol). Cochrane Database of Systematic Reviews 2003, Issue 1.CrossRefGoogle Scholar
15Mercer, JS. Current best evidence:a review of the literature on umblical cord clamping. J Midwifery Women's Health 2001; 46: 402–14.CrossRefGoogle Scholar
16WHO. Attending to 136 million births, every year:make every mother and child count. Report. Geneva, Switzerland: World Health Organization; 2005.Google Scholar
17WHO. Pregnancy, Childbirth, Postpartum and Newborn Care: a Guide for Essential Practice. Geneva: World Health Organization 2003.Google Scholar
18Jackson, KW, Albert, JR, Schemmer, GK. A randomised controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol 2001; 185: 873–77.CrossRefGoogle ScholarPubMed
19Jose, M, Ceriani, C, Carroli, G, Pellegrini, L. The effect of timing of cord clamping on neonatal venous hematocrit values and clinical outcome at term: A randomized controlled trial. Pediatr 2006; 117: e779–e786.Google Scholar
20Umblical cord blood banking. Royal College of Obstetrician and Gynaecologists. Scientific opinion 2006.Google Scholar
21Condous, GS, Arulkumaran, S, Symonds, I, Chapman, R, Sinha, A, Razvi, A. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol 2003; 101: 767–72.Google Scholar
22Johanson, R, Kumar, M, Obhrai, M, Young, P. Management of massive postpartum hemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. BJOG 2001; 108: 420–22.Google ScholarPubMed
23Frenzel, D, Condous, GS, Papageorghiou, A. The use of the “tamponade test” to stop massive obstetric haemorrhage in placenta accreta. BJOG 2005; 112: 676–77.CrossRefGoogle Scholar
24Seror, J, Allouche, C, Elhaik, S. Use of Sengstaken-Blakemore tube in massive postpartum hemorrhage: a series of 17 cases. Acta Obstet Gynecol Scand 2005; 84: 660–64.CrossRefGoogle ScholarPubMed
25Katesmark, M, Brown, R, Raju, K. Successful use of a Sengstaken-Blakemore tube to control massive postpartum haemorrhage. BJOG 1994; 101: 259–60.CrossRefGoogle ScholarPubMed
26Chan, C, Razvi, K, Tham, K, Arulkumaran, S. The use of Sengstaken-Blakemore tube to control postpartum hemorrhage. Int J Gynaecol Obstet 1997; 58: 251–52.CrossRefGoogle Scholar
27Ferrazzani, S, Guariglia, L, Caruso, A. Therapy and prevention of obstetric hemorrhage by tamponade using a balloon catheter. Minerva Ginecol 2004; 56: 481–84.Google ScholarPubMed
28Bakri, NY, Amri, A, Jabbar, FA. Tamponade balloon for obstetrical bleeding. Int J Gynaecol Obstet 2001; 58: 251–52.Google Scholar
29Mousa, HA, Alfirevic, Z. Treatment for primary postpartum hemorrhage (Cochrane Review). Cochrane Database of Systematic Reviews 2003, Issue 1 2003.CrossRefGoogle Scholar
30Baskett, TF. Surgical management of severe obstetric hemorrhage: experience with an obstetric hemorrhage tray. J Obstet Gynecol Can 2004; 26: 805–808.CrossRefGoogle ScholarPubMed
31Oyelese, Y, Smulian, JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006; 107: 927–41.CrossRefGoogle ScholarPubMed
32Shevell, T, Malone, FD. Management of obstetric hemorrhage. Semin Perinatol 2003; 27: 86–104.CrossRefGoogle ScholarPubMed
33Wu, S, Kocherginsky, M, Hibbard, UJ. Abnormal placentation: Twenty-year analysis. Am J Obstet Gynecol 2005; 192: 1458–461.CrossRefGoogle ScholarPubMed
34Carri, R, Eskander, R. Accuracy of Ultrasonography and Magnetic Resonance Imaging in the Diagnosis of Placenta Accreta. Obstet Gynecol 2006; 108: 573–81.Google Scholar
35Jose, M, Jaraquemada, P, Bruno, C. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand 2005; 84: 716–24.Google Scholar
36American college of Obstetrician and Gynecologists. Placenta accreta. ACOG Committee Opinion 2002; 266.Google Scholar
37Shellock, F, Crues, J. MR safety and the American College of Radiology White Paper. Am J Roentgenol 2002; 178: 1349–352.CrossRefGoogle ScholarPubMed
38Borgatta, L, Chen, A, Reid, S, Stubblefield, P, Christensen, D, Rashbaum, W. Pelvic embolization for treatment of hemorrhage related to spontaneous and induced abortion. Am J Obstet Gynecol 2001; 185: 530–36.CrossRefGoogle ScholarPubMed
39Ojala, K, Perala, J, Ranta, J, Raudaskoski, T, Tekay, A. Arterial embolization and prophylatic catheterization for the treatment for severe obstetric hemorrhage. Am J Obstet Gynecol 2005; 84: 1075–80.Google Scholar
40Mitty, H, Sterling, K, Alvarez, M, Gendler, R. Prophylactic and emergency arterial catheterization and embolotherapy. Radiology 1993; 188: 183–87.CrossRefGoogle ScholarPubMed
41Alvarez, M, Lockwood, C, Ghidini, A, Dottino, P, Mitty, H, Berkowitz, R. Prophylactic and emergent arterial catheterization for selective embolization in obstetric hemorrhage. Am J Perinatol 1992; 9: 441–44.CrossRefGoogle ScholarPubMed
42Dubois, J, Garel, L, Grignon, A, Lemay, M, Leduc, L. Balloon occlusion and embolization of the internal iliac arteries to reduce intraoperative blood losses. Am J Obstet Gynecol 1997; 176: 723–26.CrossRefGoogle ScholarPubMed
43Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Placenta accreta. College statement. 2005.Google Scholar
44Placenta praevia and placenta praevia accreta: diagnosis and management. Royal College of Obstetrician and Gynaecologists. (RCOG) 2005; Oct. Guideline; no. 27.Google Scholar
45Segal, S, Shemesh, IY, Blumenthal, R, Yoffe, B, Laufer, N, Ezra, Y. Treatment of obstetric hemorrhage with rFVIIa. Arch Gynecol Obstet 2003; 268: 266–67.CrossRefGoogle ScholarPubMed
46Sphan, DR, Tucci, MA, Markis, M. Is recombinant Factor VIIa the magic bullet in the treatment of bleeding disorders. Blood 2005; 104: 3858–864.Google Scholar
47Moscardo, F, Perez, F, de la Rubia, J, Balerdi, B, Lorenzo, J, Senent, M, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001; 114: 174–76.CrossRefGoogle ScholarPubMed
48Breborowicz, G, Sobieszczyk, S, Szymankiewicz, M. Efficacy of recombinant activated factor VII (rFVIIa, Novoseven) in prenatal medicine. Arch Perinat Med 2002; 8: 21–27.Google Scholar
49Tanchev, S, Platikanov, V. Administration of recombinant factor VIIa for massive bleeding due to uterine atonia in the post-placental period. Acta Obstet Gynecol Scand 2005; 84: 402–403.CrossRefGoogle ScholarPubMed
50Boyer-Neumann, C, Dreyfus, M, Wolf, M, Veyradier, A, Meyer, D. Multi-theraputic approach to manage delivery in an alloimmunized patient with type 3 Von Willebrand disease. J Thromb Haemost 2003; 1: 190–92.CrossRefGoogle Scholar
51Ahonen, J, Jokela, R. Recombinant Factor VIIa for life threatening postpartum hemorrhage. Br J Anaesth 2005; 94: 592–95.CrossRefGoogle Scholar
52Breborowicz, GH, Sobieszczyk, S. Usefuleness of recombinant active factor VIIa in obstetric practice-own experience. Klin Perinat Ginek 2001; 34: 7–12.Google Scholar
53Breborowicz, GH, Sobieszczyk, S, Szymankiewicz, M. Efficacy of recombinant activated factor VII in prenatal medicine. J Perinat Med 2003; 31: 18.Google Scholar
54Sewell, MF, Rosenblum, D, Ehrenberg, H. Arterial embolus during common iliac balloon catheterization at cesarean hysterectomy. Obstet Gynecol 2006; 108: 746–48.CrossRefGoogle ScholarPubMed
55Hong, TM, Tseng, HS, Lee, RC, Wang, JH, Chang, CY. Uterine artery embolization:an effective treatment for intractable obstetric hemorrhage. Clin Radiol 2004; 59: 96–101.CrossRefGoogle Scholar
56Hansch, E, Chitkara, U, McAlpineJ, J,El-Sayed, Y, Dake, MD, Razavi, MK. Pelvic arterial embolization for control of obstetric haemorrhage: a five-year experience. Am J Obstet Gynecol 1999; 180: 1454–460.CrossRefGoogle ScholarPubMed
57Nikolic, B, Spies, J, Lundsten, M, Abbara, S. Patient radiation dose associated with uterine artery embolization. Radiology 2000; 214: 121–25.CrossRefGoogle ScholarPubMed
58Nikolic, B, Spies, J, Campbell, L, WalshS, S,Abbara, S, Lundsten, MJ. Uterine artery embolization: Reduced radiation with refined technique. J Vasc Interv Radiol 2001; 12: 39–44.CrossRefGoogle ScholarPubMed
59Pregnancy and radiation. http://www.motherisk.org/cancer/pregnancy.php3 2001.Google Scholar
60Kim, M, Kim, N, Kim, H, Lee, M. Pregnancy following uterine artery embolization with polyvinyl alcohol particles for patients with uterine fibroid or adenomyosis. Cardiovasc Intervent Radiol 2005; 28: 611–15.CrossRefGoogle ScholarPubMed
61Vedantham, S, Goodwin, S, McLucas, B, Mohr, G. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol 1997; 176: 938–48.CrossRefGoogle ScholarPubMed
62Lewis, G, Drife, J. Why Mothers Die. The Confidential Enquiries into Maternal Death in United Kingdom. London, England 1997–1999; RCOG press; 94–103.Google Scholar
63Marsh, J, Elebute, B. Special circumstances: Jehovah's Witnesses, Those who refuse blood transfusion and/or consent. In: B-Lynch, C, Keith, LG, Lalonde, AB, Karoshi, M (eds) A textbook of “Postpartum hemorrhage”. A comprehensive guide. Sapiens UK, 2006; 147–153.Google Scholar
64Confidential Enquiry into Maternal and Child Health (CEMACH) 2000–2002. The 6th report of the Confidential Enquires into Maternal Deaths in the UK.Google Scholar
65AAGBI Guidelines for Obstetric Anaesthetic Services, Revised Edition 2005.Google Scholar
66Intra-operative blood cell salvage in obstetrics. National Institute for Health and Clinical Excellence, November 2005.Google Scholar
67Ronsmans, C, Graham, WJ. Maternal mortality: who, when and why. Lancet 2006; 368: 1189–200.CrossRefGoogle Scholar
68Frieden, TR, Novello, AC, King, J. Health Alert: Prevention of maternal deaths through improved management of hemorrhage. Letter from state of New York Departement of Health and The New York City Departement of Health and Mental Hygiene. 2004; August 9.Google Scholar
69Sheikh, L, Zuberi, NF, Riaz, R, Rizvi, JH. Massive primary postpartum hemorrage:setting up standars of care. J Pak Med Assoc 2006; 56: 26–31.Google Scholar
70Lalonde, A, Daviss, BA, Acosta, A, Herscherfer, K. Postpartum hemorrhage today:ICM/FIGO initiative 2004–2006. Int J Gynaecol Obstet 2006; 94: 243–53.CrossRefGoogle ScholarPubMed